Eye drops of interferon a-2b in post-surgical treatment of conjunctival intraepithelial neoplasia.

Center for Genetic Engineering and Biotechnology (CIGB), in Havana.0 个研究点目标入组 68 人开始时间: 2011年7月11日最近更新: 2024年8月19日

试验速览

暂无简介。

研究类型: Interventional
分配方式: Randomized controlled trial. Masking: Double Blind. Control group: Placebo. Assignment: Parallel. Purpose: Prevention

•1) Histological diagnosis of intraepithelial neoplasia of the conjunctiva. 2) Age between 18 and 75, inclusive. 3) Voluntariness of the patient by signing the Informed Consent.

•1) Patients who present at diagnosis, inflammatory and infectious eye diseases such as uveitis active, severe corneal ulcer and endophthalmitis. 2) bilateral tumor lesion of the ocular conjunctiva. 3) hypersensitivity to IFN or other component of the formulation. 4) antiviral treatment (including IFN via any route) in the last 30 days. 5) Pregnancy or lactation at the time of inclusion in the study. 6) Mental incapacity to give consent clearly and act accordingly to the study.

发起方

Center for Genetic Engineering and Biotechnology (CIGB), in Havana.